Use of pyrosequencing to detect clinically relevant polymorphisms in dihydropyrimidine dehydrogenase

被引：19

作者：

Ahluwalia, R ^{[1
]}

Freimuth, R ^{[1
]}

McLeod, HL ^{[1
]}

Marsh, S ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Div Oncol, St Louis, MO 63110 USA

来源：

CLINICAL CHEMISTRY | 2003年 / 49卷 / 10期

关键词：

D O I：

10.1373/49.10.1661

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：1661 / 1664

页数：4

共 20 条

[1]

Ando Y, 2000, CANCER RES, V60, P6921

[2] Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine [J].

Black, AJ ;

McLeod, HL ;

Capell, HA ;

Powrie, RH ;

Matowe, LK ;

Pritchard, SC ;

Collie-Duguid, ESR ;

Reid, DM .

ANNALS OF INTERNAL MEDICINE, 1998, 129 (09) :716-718

[3] The essence of SNPs [J].

Brookes, AJ .

GENE, 1999, 234 (02) :177-186

[4] Known variant DPYD alleles do not explain DPD deficiency in cancer patients [J].

Collie-Duguid, ESR ;

Etienne, MC ;

Milano, G ;

McLeod, HL .

PHARMACOGENETICS, 2000, 10 (03) :217-223

[5] Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness [J].

Drysdale, CM ;

McGraw, DW ;

Stack, CB ;

Stephens, JC ;

Judson, RS ;

Nandabalan, K ;

Arnold, K ;

Ruano, G ;

Liggett, SB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10483-10488

[6] Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects [J].

Evans, WE ;

McLeod, HL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :538-549

[7] Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population [J].

Hamdy, SI ;

Hiratsuka, M ;

Narahara, K ;

El-Enany, M ;

Moursi, N ;

Ahmed, MSE ;

Mizugaki, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (06) :596-603

[8] UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity [J].

Iyer L. ;

Das S. ;

Janisch L. ;

Wen M. ;

Ramírez J. ;

Karrison T. ;

Fleming G.F. ;

Vokes E.E. ;

Schilsky R.L. ;

Ratain M.J. .

The Pharmacogenomics Journal, 2002, 2 (1) :43-47

[9] Notes from the SNP vs. haplotype front [J].

Judson, R ;

Stephens, JC .

PHARMACOGENOMICS, 2001, 2 (01) :7-10

[10] PHARMACOGENETICS OF ACUTE AZATHIOPRINE TOXICITY - RELATIONSHIP TO THIOPURINE METHYLTRANSFERASE GENETIC-POLYMORPHISM [J].

LENNARD, L ;

VANLOON, JA ;

WEINSHILBOUM, RM .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :149-154

← 1 2 →